Valuation: Repligen Corporation

Market Cap 8.3B 7.21B 6.73B 6.18B 11.66B 791B 11.86B 79.27B 31.06B 394B 31.17B 30.48B 1,306B P/E 2026 *
188x
P/E 2027 * 83.5x
Enterprise Value 8.1B 7.04B 6.57B 6.04B 11.38B 773B 11.58B 77.41B 30.33B 385B 30.44B 29.77B 1,275B EV / Sales 2026 *
9.8x
EV / Sales 2027 * 8.17x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day+4.29%
1 week+11.44%
Current month+4.29%
1 month+3.27%
3 months+25.48%
6 months-2.69%
Current year-10.25%
1 week 137.35
Extreme 137.35
154
1 month 129
Extreme 129
154
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap.
7/16/26 Sell

Chief Financial Officer

-530 0.0009%
6/25/26 Sell

Chief Financial Officer

-733 0.0013%
5/14/26 Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+4.29%+11.44%+23.67%-13.74% 7.96B
+1.34%+3.94%-15.85%-1.38% 183B
+1.51%+4.17%-2.98%+1.43% 109B
-0.95%-0.49%+6.94%+61.09% 60.57B
+2.37%+2.85%+44.34%+56.22% 51.8B
+2.77%+8.86%-3.49%-38.38% 45.64B
+3.03%+4.44% - - 33.22B
+4.63%+22.04%+10.13%-29.48% 31.49B
+2.05%+6.01%+45.42%-6.11% 24B
+1.86%+8.67%+2.54%+2.12% 22.26B
Average +2.12%+4.75%+12.30%+3.53% 56.91B
Weighted average by Cap. +1.17%+3.42%+1.84%+6.77%

Financials

2026 *2027 *
Net sales 827M 719M 670M 616M 1.16B 78.84B 1.18B 7.9B 3.1B 39.31B 3.11B 3.04B 130B 969M 842M 785M 722M 1.36B 92.39B 1.39B 9.26B 3.63B 46.06B 3.64B 3.56B 153B
Net income 43.07M 37.43M 34.91M 32.08M 60.5M 4.11B 61.55M 411M 161M 2.05B 162M 158M 6.78B 101M 87.72M 81.8M 75.17M 142M 9.62B 144M 964M 378M 4.8B 379M 371M 15.89B
Net Debt -195M -169M -158M -145M -274M -18.57B -278M -1.86B -729M -9.26B -731M -715M -30.65B -379M -329M -307M -282M -532M -36.09B -541M -3.62B -1.42B -17.99B -1.42B -1.39B -59.57B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-08-03 $147.06 +4.29% 1,010,517
26-07-31 $141.01 -1.80% 875,270
26-07-30 $143.60 +1.68% 1,042,805
26-07-29 $141.23 -2.83% 1,514,030
26-07-28 $145.34 +10.90% 2,508,130
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
147.06USD
Average target price
185.70USD
Spread / Average Target
+26.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock